- Nitrogen-containing compound, electronic element, and electronic device
-
The invention belongs to the technical field of organic materials, and provides a nitrogen-containing compound, an electronic element and an electronic device. The structure of the nitrogen-containingcompound is shown as a formula 1, wherein X1, X2 and X3 are respectively and independently selected from C or N, and at least one of X1, X2 and X3 is N; wherein R1, R2 and R3 are respectively and independently selected from hydrogen or a group shown in a chemical formula 1-1, and only one of R1, R2 and R3 is a group shown in a chemical formula 1-1. The nitrogen-containing compound can improve theperformance of an electronic component.
- -
-
Paragraph 0202-0203
(2020/07/24)
-
- CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
-
A condensed cyclic compound represented by Formula 1: An organic light-emitting device including a first electrode; a second electrode facing the first electrode; and an organic layer between the first electrode and the second electrode, the organic layer including an emission layer, and further including at least one of the condensed cyclic compounds of Formula 1.
- -
-
Paragraph 0376; 0377; 0378; 0379; 0395; 0396; 0397
(2016/11/02)
-
- Flow Chemistry on Multigram Scale: Continuous Synthesis of Boronic Acids within 1 s
-
The benefits and limitations of a simple continuous flow setup for handling and performing of organolithium chemistry on the multigram scale is described. The developed metalation platform embodies a valuable complement to existing methodologies, as it combines the benefits of Flash Chemistry (chemical synthesis on a time scale of 1 s) with remarkable throughput (g/min) while mitigating the risk of blockages.
- Hafner, Andreas,Meisenbach, Mark,Sedelmeier, Joerg
-
supporting information
p. 3630 - 3633
(2016/08/16)
-
- CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME
-
A condensed-cyclic compound is represented by Formula 1: where X1 and R1 to R10 are as defined in the specification, and at least one of R1 to R10 is a group represented by Formula 2, and at least one of R1 to R10 is a group represented by Formula 3: where L1, L2, Ar1 to Ar4, a1 and a2 are as defined in the specification.
- -
-
Paragraph 0261; 0262; 0263
(2016/08/03)
-
- CONDENSED-CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING THE SAME
-
A condensed-cyclic compound is represented by Formula 1: where X, L1 to L3, R1 to R3, Ar1 to Ar6, c1 to c3, a1 to a2, and b1 to b3 are as defined in the specification
- -
-
Paragraph 0271; 0272
(2016/08/03)
-
- New 5-aryl-1H-imidazoles display in vitro antitumor activity against apoptosis-resistant cancer models, including melanomas, through mitochondrial targeting
-
We designed and synthesized 48 aryl-1H-imidazole derivatives and investigated their in vitro growth inhibitory activity in cancer cell lines known to present various levels of resistance to proapoptotic stimuli. The IC50 in vitro growth inhibitory concentration of these compounds ranged from >100 μM to single digit μM. Among the most active compounds, 2i displayed similar in vitro growth inhibition in cancer cells independent of the cells' levels of resistance to proapoptotic stimuli and was found to be cytostatic in melanoma cell lines. Compound 2i was then tested by the National Cancer Institute Human Tumor Cell Line Anti-Cancer Drug Screen, and the NCI COMPARE algorithm did not reveal any correlation between its growth inhibition profiles with the NCI database compound profiles. The use of transcriptomically characterized melanoma models then enabled us to highlight mitochondrial targeting by 2i. This hypothesis was further confirmed by reactive oxygen production measurement and oxygen consumption analysis.
- Mathieu, Véronique,Van Den Berge, Emilie,Ceusters, Justine,Konopka, Tomasz,Cops, Antonin,Bruyère, Céline,Pirker, Christine,Berger, Walter,Trieu-Van, Tran,Serteyn, Didier,Kiss, Robert,Robiette, Rapha?l
-
p. 6626 - 6637
(2013/10/01)
-
